COSM
Cosmos Health Inc.
COSM offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
UNH
UnitedHealth Group Incorporated
UNH has the edge over COSM overall, supported by lower modeled downside and stronger valuation.
COSM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Weak | |
| Weak |
COSM's revenue is currently healthy, but its profitability, cash flow and balance sheet are under pressure.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
COSM PE Valuation
COSM has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 2.1x next year's earnings.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
COSM Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
COSM has the edge over UNH on the outlook, with more favorable revenue expectations.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
COSM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.10 | — |
| Q2 2026 | -$0.66 | +$0.38 |
| Q1 2026 | -$0.66 | +$0.43 |
| Q4 2025 | -$0.63 | +$0.54 |
| Q3 2025 | -$0.76 | +$1.70 |
| Q2 2025 | -$1.04 | +$1.24 |
| Q1 2025 | -$1.09 | +$1.13 |
| Q4 2024 | -$1.17 | +$0.98 |
| Q3 2021 | -$11.50 | -454% |
COSM is still losing money, but far less than before: $0.66 per share over the past year, against $25.00 at its worst in late 2019.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH has the edge over COSM on earnings quality, reporting a profit while its opponent remains loss making.
COSM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $19M | +29% |
| Q1 2026 | $17.9M | +31% |
| Q4 2025 | $19.7M | +39% |
| Q3 2025 | $17.1M | +38% |
| Q2 2025 | $14.7M | +12% |
| Q1 2025 | $13.7M | -6% |
| Q4 2024 | $14.2M | -10% |
| Q3 2024 | $12.4M | -3.2% |
COSM's revenue has grown year over year for five quarters in a row: $19M last quarter, up 29% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -15% | +2.5 points |
| Q1 2026 | -12% | -6.1 points |
| Q4 2025 | -58% | +5.1 points |
| Q3 2025 | -11% | +7.4 points |
| Q2 2025 | -18% | +1 points |
| Q1 2025 | -6.1% | +6.5 points |
| Q4 2024 | -63% | +23 points |
| Q3 2024 | -18% | +5.5 points |
COSM's operating margin was −15% last quarter, up 2.5 points from the same quarter a year ago.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH's revenue has held roughly level: $113B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH has the edge over COSM on profitability, with a higher operating margin.
COSM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$1.8M | -$549.4K |
| Q1 2026 | -$1.1M | -$879.6K |
| Q4 2025 | -$4.6M | -$697.9K |
| Q3 2025 | -$2.5M | -583% |
| Q2 2025 | -$1.2M | +$12.6K |
| Q1 2025 | -$198.8K | +$3.3M |
| Q4 2024 | -$3.9M | -532% |
| Q3 2024 | $511K | +$5.1M |
COSM has burned cash in almost every quarter: −$10M over the past year, against −$5M the year before.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH has the edge over COSM on cash generation, producing positive trailing cash flow while its opponent burns cash.
COSM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2021 | 8.5x | High |
| Q4 2020 | 3.3x | Elevated |
| Q3 2020 | -0.3x | Net Cash |
| Q2 2020 | -1.1x | Net Cash |
| Q1 2020 | -1.9x | Net Cash |
| Q4 2019 | 0.6x | Very low |
COSM's net debt is about 8.5 years of its operating earnings (EBITDA), after holding more cash than debt a year ago.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
COSM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.5 | Neutral |
| Stochastic | 31.7 | Neutral |
COSM's weekly RSI is 41 (neutral) and its Stochastic is 32 (neutral).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
COSM PE vs Healthcare Sector
| Metric | COSM | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
COSM has no meaningful PE right now: it lost money over the past year.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
COSM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.31 | 32% below |
| 20 week MA | $0.27 | 22% below |
| 50 week MA | $0.33 | 36% below |
| 100 week MA | $0.49 | 57% below |
| 200 week MA | $1.10 | 81% below |
COSM is in a downtrend: it's below all five of its weekly moving averages, and 81% below its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over COSM on trend strength, trading above more of its moving averages.
COSM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $62.5 | $127.5 | +104% |
| 2021 | $127.5 | $99.0 | -22% |
| 2022 | $99.0 | $6.40 | -94% |
| 2023 | $6.40 | $1.41 | -78% |
| 2024 | $1.41 | $0.68 | -52% |
| 2025 | $0.68 | $0.51 | -25% |
| 2026 YTD | $0.51 | $0.21 | -59% |
COSM has finished five years in a row lower, and it's down 59% so far in 2026.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over COSM on returns for 2026, with the stronger performance.